NEW YORK--(BUSINESS WIRE)--Barclays Bank PLC (“Barclays”) announced today the launch of its consent solicitation (the “Consent Solicitation”) for the iPath® Dow Jones-UBS Coffee Subindex Total ReturnSM ETN (“the ETNs”).
Barclays is soliciting consents (the “Consents”) for the ETNs to the proposed amendments described below (collectively, the “Proposed Amendment”) on the terms and conditions as set forth in the Consent Solicitation Statement, dated February 11, 2014 (the “Consent Solicitation Statement”) and the accompanying Voter Instruction Form (the “VIF”). Consents are being solicited from each person in whose name beneficial ownership of an issue of Existing ETNs was recorded as of 5:00 p.m., Eastern Standard Time, on January 28, 2014, the record date for the Consent Solicitation.
The Consent Solicitation will expire on March 31, 2014, or such earlier date (the “Effective Time”) on which the approval of holders of a majority in aggregate principal amount (the “Required Consents”) of the ETNs is received and Barclays declares the Proposed Amendment to be effective. Barclays may terminate or extend the Consent Solicitation at any time in its sole discretion.
If the Required Consents are received for the ETNs in accordance with the Consent Solicitation Statement, the Proposed Amendment would amend the terms to provide Barclays with the following unqualified rights as of the date on which the Proposed Amendment is made effective:
- the right to redeem all, but not less than all, of the outstanding ETNs, prior to maturity, on the terms described in the Consent Solicitation Statement; and
- the right to initiate a split or reverse split of the ETNs on the terms described in the Consent Solicitation Statement.
In addition, if the Required Consents are received the ETNs in accordance with the Consent Solicitation Statement, the Proposed Amendment would also amend the terms as follows:
- The investor fee for the ETNs would be reduced during the period from the Effective Time of the Proposed Amendment for that issue to the maturity date of the ETNs. The reduced investor fee would be an amount equal to 0.70% per annum times the principal amount of a holder’s ETNs times the relevant index factor, calculated on a daily basis. The current investor fee is an amount equal to 0.75% per annum times the principal amount of a holder’s ETNs times the relevant index factor, calculated on a daily basis.
- The minimum number of the ETNs required to be redeemed for a holder to exercise its right to redeem ETNs prior to maturity will be reduced from 50,000 ETNs to 30,000 ETNs.
The Proposed Amendment for the ETNs cannot be partitioned and will take effect as a single proposal if all conditions are met. If any conditions fail to be met for the ETNs, none of the amendments listed above will become effective.
Under the indenture relating to the ETNs, the Depository Trust Company (“DTC”), as registered holder of the ETNs, must deliver (and not revoke) valid Consents in respect of at least a majority in aggregate principal amount of the outstanding ETNs of an issue to approve the Proposed Amendment with respect to that issue. For purposes of the Consent Solicitation, DTC has provided an omnibus proxy to the financial institutions acting as participants in its system to submit Consents on its behalf and such financial institutions have, in turn, provided proxies to Broadridge Financial Solutions, Inc. (“Broadridge”) to submit Consents on their behalf after soliciting and obtaining consent to the Proposed Amendment from the beneficial owners of the ETNs.
The process for vote submission described in the Consent Solicitation Statement allows beneficial owners of the ETNs to submit their Consents to the Proposed Amendment to Broadridge, which has been engaged by Barclays as the solicitation agent and tabulation agent for the Consent Solicitation. The Consent Solicitation is subject to the terms and conditions of the Consent Solicitation Statement and the VIF, including with respect to the timing for delivering Consents and the effectiveness of the Proposed Amendment.
None of Barclays, Broadridge, The Bank of New York Mellon (in its capacity as indenture trustee for the ETNs) or any of their respective subsidiaries or affiliates makes any recommendation as to whether beneficial owners of the ETNs should deliver Consents to the Proposed Amendment pursuant to the Consent Solicitation, and no one has been authorized by any of them to make such a recommendation. The Consent Solicitation Statement and the VIF, which contain important information regarding the terms and conditions of the Consent Solicitation and the respective rights and obligations of Barclays and the beneficial owners of the ETNs, should be read before any decision is made with respect to the Consent Solicitation.
Any questions or requests for assistance concerning the Consent Solicitation may be directed to Broadridge, the solicitation agent and tabulation agent for the Consent Solicitation, at the following address and telephone number:
Broadridge Financial Solutions, Inc.
1155 Long Island Avenue, Edgewood, NY 11717
Attn: Barclays Commodities Consent Solicitation
Consents may be submitted as follows:
|By First Class Mail:||By Courier:|
|Proxy Services||Broadridge Financial Solutions, Inc.|
|P.O. Box 9175||1155 Long Island Ave.|
|Farmingdale, NY 11735-9847||Edgewood, NY 11717|
|By Electronic Communication:||To Confirm Please Call:|
About iPath® ETNs
An investment in iPath ETNs involves significant risks and may not be suitable for all investors. The ETNs are riskier than ordinary unsecured debt securities and have no principal protection. For more information on risks associated with the ETNs, please see "Selected Risk Considerations" below and the risk factors included in the relevant prospectus.
Selected Risk Considerations
An investment in the iPath ETNs described herein (the “ETNs”) involves risks. Selected risks are summarized here, but we urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement and pricing supplement.
You May Lose Some or All of Your Principal: The ETNs are exposed to any decrease in the level of the underlying index between the inception date and the applicable valuation date. Additionally, if the level of the underlying index is insufficient to offset the negative effect of the investor fee and other applicable costs, you will lose some or all of your investment at maturity or upon redemption, even if the value of such index has increased. Because the ETNs are subject to an investor fee and any other applicable costs, the return on the ETNs will always be lower than the total return on a direct investment in the index components. The ETNs are riskier than ordinary unsecured debt securities and have no principal protection.
Credit of Barclays Bank PLC: The ETNs are unsecured debt obligations of the issuer, Barclays Bank PLC, and are not, either directly or indirectly, an obligation of or guaranteed by any third party. Any payment to be made on the ETNs, including any payment at maturity or upon redemption, depends on the ability of Barclays Bank PLC to satisfy its obligations as they come due. As a result, the actual and perceived creditworthiness of Barclays Bank PLC will affect the market value, if any, of the ETNs prior to maturity or redemption. In addition, in the event Barclays Bank PLC were to default on its obligations, you may not receive any amounts owed to you under the terms of the ETNs.
Market and Volatility Risk: The prices of physical commodities, including the commodities underlying the index components, can fluctuate widely due to supply and demand disruptions in major producing or consuming regions. Additionally, the market value of the ETNs may be influenced by many unpredictable factors including changes in supply and demand relationships, governmental policies and economic events.
A Trading Market for the ETNs May Not Develop: Although the ETNs are listed on NYSE Arca, a trading market for the ETNs may not develop and the liquidity of the ETNs may be limited, as we are not required to maintain any listing of the ETNs.
No Interest Payments from the ETNs: You may not receive any interest payments on the ETNs.
Restrictions on the Minimum Number of ETNs and Date Restrictions for Redemptions: You must redeem at least 50,000 ETNs (30,000 ETNs if the Proposed Amendment is accepted for an issue) of the same issue at one time in order to exercise your right to redeem your ETNs on any redemption date. You may only redeem your ETNs on a redemption date if we receive a notice of redemption from you by certain dates and times as set forth in the pricing supplement.
Uncertain Tax Treatment: Significant aspects of the tax treatment of the ETNs are uncertain. You should consult your own tax advisor about your own tax situation.
Barclays Bank PLC has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus and other documents Barclays Bank PLC has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting www.iPathETN.com or EDGAR on the SEC website at www.sec.gov. Alternatively, Barclays Bank PLC will arrange for Barclays Capital Inc. to send you the prospectus if you request it by calling toll-free 1-877-764-7284, or you may request a copy from any other dealer participating in the offering.
BlackRock Investments, LLC, assists in the promotion of the ETNs.
The ETNs may be sold throughout the day on the exchange through any brokerage account. There are restrictions on the minimum number of ETNs you may redeem directly with the issuer as specified in the applicable prospectus. Commissions may apply and there are tax consequences in the event of sale, redemption or maturity of ETNs. Sales in the secondary market may result in significant losses.
The Dow Jones-UBS Commodity IndexesSM are a joint product of DJI Opco, LLC (“DJI Opco”), a subsidiary of S&P Dow Jones Indices LLC (“SPDJI”), and UBS Securities LLC (“UBS Securities”). Dow Jones®, “Dow Jones-UBS Coffee Subindex Total ReturnSM”, and “DJ-UBSCISM” are servicemarks and/or trademarks of Dow Jones Trademark Holdings, LLC (“Dow Jones”) and “UBS” is a registered trademark of UBS AG (“UBS AG”). These servicemarks and/or trademarks have been licensed to DJI Opco and sublicensed to Barclays Bank PLC for certain purposes. The Dow Jones-UBS Commodity IndexesSM (the “Commodity Indices”) have been licensed to Barclays Bank PLC for certain purposes. The ETNs based on the indices are not sponsored, endorsed, sold or promoted by Dow Jones, UBS, UBS AG, Dow Jones Opco or any of their respective subsidiaries or affiliates, and none of Dow Jones, UBS, UBS AG, Dow Jones Opco or any of their respective affiliates, makes any representation or warranty, express or implied, to the owners of or counterparts to the ETNs based on the indices or any member of the public regarding the advisability of investing in securities or commodities generally or in the ETNs based on any of the indices particularly.
© 2014 Barclays Bank PLC. All rights reserved. iPath, iPath ETNs and the iPath logo are registered trademarks of Barclays Bank PLC. All other trademarks, servicemarks or registered trademarks are the property, and used with the permission, of their respective owners.
NOT FDIC INSURED · NO BANK GUARANTEE · MAY LOSE VALUE
Barclays is a major global financial services provider engaged in personal banking, credit cards, corporate and investment banking and wealth and investment management with an extensive international presence in Europe, the Americas, Africa and Asia. Barclays’ purpose is to help people achieve their ambitions – in the right way. With over 300 years of history and expertise in banking, Barclays operates in over 50 countries and employs approximately 140,000 people. Barclays moves, lends, invests and protects money for customers and clients worldwide. Barclays offers premier investment banking products and services to its clients through Barclays Bank PLC. For more information, visit www.barclays.com